There were no adverse events related to atherosclerotic cardiovascular disease during a median 3.7 years of follow-up for 101 patients with familial hypercholesterolemia (FH) but a coronary artery calcium (CAC) score of zero, according to a study published Nov. 14 in JACC: Cardiovascular Imaging.

Sales representatives from medical device companies can provide training and expertise on the latest implantable gadgets but may also be encouraged to upsell physicians on the newest, most expensive products, according to a Nov. 23 article in NPR.

Monitoring digoxin concentration and platelet activation in atrial fibrillation (AF) patients treated with vitamin K antagonists could be important for reducing those patients’ inherently elevated risk for CVD, according to a study published in the Journal of the American Heart Association Nov. 15.

Half a decade of planning and millions of dollars have culminated in the Alliance for Cardiovascular Diagnostic and Treatment Innovation (ADVANCE), a joint engineering and cardiology center launched by Johns Hopkins University in an attempt to improve the diagnosis and treatment of a range of arrhythmia disorders.

Scientists at the University of Oxford are pitching cardiologists a new model for heart regeneration research: the Mexican tetra fish, a blind, translucent animal with an innate ability to repair its damaged heart tissue.

Even after adjusting for cardiovascular, behavioral and socioeconomic factors, black adults remain twice as likely to die from sudden cardiac death (SCD) as whites, suggests a study published in the Journal of the American College of Cardiology.

The FDA is backing a new “qualified health claim” that oils high in oleic acid can help improve cholesterol levels and protect against coronary heart disease, Commissioner Scott Gottlieb, MD, announced Nov. 19.

Employees who are bullied on the job or experience workplace violence see between a 25 and 59 percent increased risk for cardiovascular disease in their lifetime, researchers reported in the European Heart Journal.

Despite recent actions by the Centers for Medicare and Medicaid Services (CMS) to remove restrictions around MRIs for heart patients with implantable cardiovascular devices, the U.S. government is failing to protect a subset of those patients with fractured, epicardial or abandoned leads, according to an editorial published in JAMA Cardiology this November.

Diabetics who have transitioned to an employer-mandated, high-deductible insurance plan are significantly more likely to delay healthcare visits for macrovascular symptoms, diagnostic tests and procedures, researchers reported Nov. 20 in the Annals of Internal Medicine.